4 assets in Rhabdoid Tumor Of The Kidney

Therapeutic assets addressing Rhabdoid Tumor Of The Kidney, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cabozantinib Rhabdoid Tumor Of The Kidney	National Cancer Institute (NCI)	P3	B (60)
Nivolumab Rhabdoid Tumor Of The Kidney	National Cancer Institute (NCI)	P3	B (60)
Ipilimumab Rhabdoid Tumor Of The Kidney	National Cancer Institute (NCI)	P3	B (59)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)- Rhabdoid Tumor Of The Kidney	National Cancer Institute (NCI)	P2	CCC (53)